0001752724-21-117842.txt : 20210528 0001752724-21-117842.hdr.sgml : 20210528 20210528100014 ACCESSION NUMBER: 0001752724-21-117842 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210528 PERIOD START: 20211231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FOXBY CORP. CENTRAL INDEX KEY: 0001068897 IRS NUMBER: 391966806 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-09261 FILM NUMBER: 21976837 BUSINESS ADDRESS: STREET 1: 11 HANOVER SQUARE CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 2127850900 MAIL ADDRESS: STREET 1: 11 HANOVER SQUARE CITY: NEW YORK STATE: NY ZIP: 10005 FORMER COMPANY: FORMER CONFORMED NAME: FOXBY CORP DATE OF NAME CHANGE: 20030716 FORMER COMPANY: FORMER CONFORMED NAME: INTERNET GROWTH FUND INC DATE OF NAME CHANGE: 20020723 FORMER COMPANY: FORMER CONFORMED NAME: LCM INTERNET GROWTH FUND INC DATE OF NAME CHANGE: 19980825 NPORT-P 1 primary_doc.xml NPORT-P false 0001068897 XXXXXXXX Foxby Corp. 811-09261 0001068897 5493000W7P09VQYLUO04 11 Hanover Square New York 10005 212-785-0900 Foxby Corp. 5493000W7P09VQYLUO04 2021-12-31 2021-03-31 N 11576058.97 505575.16 11070483.81 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0 N Williams-Sonoma Incorporation 549300IARG6YWVTZ1I92 Williams-Sonoma, Inc. 969904101 2500.00000000 NS USD 448000.00000000 4.046796939401 Long EC CORP US N 1 N N N Humana Inc. 529900YLDW34GJAO4J06 Humana, Inc. 444859102 450.00000000 NS USD 188662.50000000 1.704193811562 Long EC CORP US N 1 N N N Westlake Chemical Corporation GOXNEVUM0LL78B1OS344 Westlake Chemical Corp. 960413102 2100.00000000 NS USD 186459.00000000 1.684289532419 Long EC CORP US N 1 N N N Mastec, Inc. 549300TMDIT8WREDOF45 MasTec, Inc. 576323109 1700.00000000 NS USD 159290.00000000 1.438871170708 Long EC CORP US N 1 N N N Tyson Foods, Inc. WD6L6041MNRW1JE49D58 Tyson Foods, Inc. 902494103 3950.00000000 NS USD 293485.00000000 2.651058481607 Long EC CORP US N 1 N N N KforceCom Inc 5493003RDQQDVXY2SK46 Kforce, Inc. 493732101 4600.00000000 NS USD 246560.00000000 2.227183601291 Long EC CORP US N 1 N N N Enova International, Incorporation 549300O8XOCQSB49UO63 Enova International, Inc. 29357K103 4600.00000000 NS USD 163208.00000000 1.474262577870 Long EC CORP US N 1 N N N N/A N/A Reich & Tang Deposit Account N/A 2830.21000000 PA USD 2830.21000000 0.025565368673 Long STIV US N 1 N N N Tractor Supply Co 549300OJ9VZHZRO6I137 Tractor Supply Co. 892356106 1800.00000000 NS USD 318744.00000000 2.879223758152 Long EC CORP US N 1 N N N Ameriprise Financial, Inc. 6ZLKQF7QB6JAEKQS5388 Ameriprise Financial, Inc. 03076C106 1200.00000000 NS USD 278940.00000000 2.519673076510 Long EC CORP US N 1 N N N Check Point Sftwre 2549003ZVBH73EPNS513 Check Point Software Technologies Ltd. M22465104 4500.00000000 NS USD 503865.00000000 4.551427097927 Long EC CORP IL N 1 N N N BlackRock, Inc. 549300LRIF3NWCU26A80 BlackRock, Inc. 09247X101 400.00000000 NS USD 301584.00000000 2.724216982527 Long EC CORP US N 1 N N N Autozone, Inc. GA3JGKJ41LJKXDN23E90 AutoZone, Inc. 053332102 335.00000000 NS USD 470440.50000000 4.249502624041 Long EC CORP US N 1 N N N Bm Technologies Inc N/A BM Technologies, Inc. 05591L107 3078.00000000 NS USD 35858.70000000 0.323912672792 Long EC CORP US N 1 N N N Accenture Plc N/A Accenture PLC G1151C101 80.00000000 NS USD 22100.00000000 0.199629938305 Long EC CORP IE N 1 N N N Valvoline Inc 549300CMHPBEY6VPOT75 Valvoline, Inc. 92047W101 8000.00000000 NS USD 208560.00000000 1.883928503753 Long EC CORP US N 1 N N N Price T Rowe Group 549300SIV6FPS9Y7IH33 T. Rowe Price Group, Inc. 74144T108 2101.00000000 NS USD 360531.60000000 3.256692355887 Long EC CORP US N 1 N N N The Home Depot, Inc. QEKMOTMBBKA8I816DO57 Home Depot, Inc./The 437076102 850.00000000 NS USD 259462.50000000 2.343732256449 Long EC CORP US N 1 N N N Celanese Corporation 549300FHJQTDPPN41627 Celanese Corp. 150870103 1500.00000000 NS USD 224715.00000000 2.029857085351 Long EC CORP US N 1 N N N Amgen Inc. 62QBXGPJ34PQ72Z12S66 Amgen, Inc. 031162100 2050.00000000 NS USD 510060.50000000 4.607391228369 Long EC CORP US N 1 N N N Medifast Inc 5299000YHQJ21T5KKI80 Medifast, Inc. 58470H101 1500.00000000 NS USD 317730.00000000 2.870064266866 Long EC CORP US N 1 N N N Intel Corporation KNX4USFCNGPY45LOCE31 Intel Corp. 458140100 8300.00000000 NS USD 531200.00000000 4.798344942433 Long EC CORP US N 1 N N N United Health Group Incorporated 549300GHBMY8T5GXDE41 UnitedHealth Group, Inc. 91324P102 1625.00000000 NS USD 604613.75000000 5.461493466562 Long EC CORP US N 1 N N N N/A N/A Amerivon Holdings N/A 245268.00000000 NS USD 88296.48000000 0.797584654071 Long EC CORP US Y 3 N N N Anthem Inc 8MYN82XMYQH89CTMTH67 Anthem, Inc. 036752103 440.00000000 NS USD 157938.00000000 1.426658515658 Long EC CORP US N 1 N N N Customers Bancorp, Inc. 549300WLBCHYKZ53FN68 Customers Bancorp, Inc. 23204G100 20000.00000000 NS USD 636400.00000000 5.748619580881 Long EC CORP US N 1 N N N Sleep Number Corporation 529900W0TZQLBT2DSS66 Sleep Number Corp. 83125X103 4150.00000000 NS USD 595483.50000000 5.379019654607 Long EC CORP US N 1 N N N Robert Half Intl 529900VPCUY9H3HLIC08 Robert Half International, Inc. 770323103 4300.00000000 NS USD 335701.00000000 3.032396828915 Long EC CORP US N 1 N N N Alphabet Inc. 5493006MHB84DD0ZWV18 Alphabet, Inc. 02079K305 500.00000000 NS USD 1031260.00000000 9.315401365462 Long EC CORP US N 1 N N N Arista Networks Inc 635400H1WKBLOQERUU95 Arista Networks, Inc. 040413106 290.00000000 NS USD 87548.10000000 0.790824515916 Long EC CORP US N 1 N N N Essent Group Limited 254900QUO860OUT6ZF83 Essent Group Ltd. G3198U102 10500.00000000 NS USD 498645.00000000 4.504274687160 Long EC CORP BM N 1 N N N Southwest Airlines Co. UDTZ87G0STFETI6HGH41 Southwest Airlines Co. 844741108 3000.00000000 NS USD 183180.00000000 1.654670230713 Long EC CORP US N 1 N N N OneMain Holdings Incorporation 549300E3VEW8SMS5XW09 OneMain Holdings, Inc. 68268W103 3600.00000000 NS USD 193392.00000000 1.746915521662 Long EC CORP US N 1 N N N Nu Skin Enterprises, Inc. 54930050DETB6CP71D38 Nu Skin Enterprises, Inc. 67018T105 4050.00000000 NS USD 214204.50000000 1.934915435281 Long EC CORP US N 1 N N N N/A N/A Amerivon Holdings Co. N/A 72728.00000000 NS USD 0.00000000 0.000000 Long EC CORP US Y 3 N N N Credit Acceptance Corporation of Michigan N/A Credit Acceptance Corp. 225310101 1000.00000000 NS USD 360230.00000000 3.253967994376 Long EC CORP US N 1 N N N Discover Financial Services Z1YLO2USPORE63VVUL20 Discover Financial Services 254709108 2300.00000000 NS USD 218477.00000000 1.973509051182 Long EC CORP US N 1 N N N Rio Tinto plc 213800YOEO5OQ72G2R82 Rio Tinto PLC 767204100 3500.00000000 NS USD 271775.00000000 2.454951424566 Long EC CORP GB N 1 N N N 2021-04-22 Foxby Corp. Gregory Knoth Gregory Knoth SVP, Mutual Fund Controller XXXX NPORT-EX 2 fxby_nport.htm MIDAS N-PORT EX FILE
 
FOXBY CORP.
 
 
SCHEDULE OF PORTFOLIO INVESTMENTS
 
 
March 31, 2021
 
 
(Unaudited)
 
     
 Shares
 
 Value
 
Common Stocks (103.14%)
 
 
Automotive Dealers and Gasoline Service Stations (4.25%)
 
                  335
AutoZone, Inc. (a)
                470,441
     
 
Building Materials, Hardware, Garden Supply (5.22%)
 
850
The Home Depot, Inc.
                259,463
               1,800
Tractor Supply Company
                318,744
   
                578,207
     
 
Business Services (19.33%)
 
                    80
Accenture plc
                  22,100
                  500
Alphabet Inc. Class A (a)
             1,031,260
               4,500
Check Point Software Technologies Ltd. (a)
                503,865
               4,600
Kforce Inc.
246,560
               4,300
Robert Half International Inc.
                335,701
   
             2,139,486
     
 
Chemical and Allied Products (8.32%)
 
               2,050
Amgen Inc.
                510,061
               1,500
Celanese Corporation
                224,715
               2,100
Westlake Chemical Corporation
                186,459
   
                921,235
     
 
Depository Institutions (6.07%)
 
               3,078
BM Technologies, Inc. (a)
                  35,858
             20,000
Customers Bancorp, Inc. (a)
                636,400
   
                672,258
     
 
Electronic and Other Electrical Equipment and Components, except Computer Equipment (4.80%)
 
               8,300
Intel Corporation
531,200
     
 
Food and Kindred Products (5.52%)
 
               1,500
Medifast, Inc.
                317,730
               3,950
Tyson Foods, Inc.
                293,485
   
                611,215
     
 
Furniture and Fixtures (5.38%)
 
               4,150
Sleep Number Corporation (a)
                595,484
     
 
Heavy Construction other than Building Construction Contractors (1.44%)
 
               1,700
MasTec, Inc. (a)
                159,290
     
 
Home Furniture, Furnishings, and Equipment Stores (4.05%)
 
               2,500
Williams-Sonoma, Inc.
                448,000
     
 
Industrial and Commerical Machinery and Computer Equipment (0.79%)
 
                  290
Arista Networks, Inc. (a)
                  87,548
     
 
Insurance Carriers (13.10%)
 
                  440
Anthem, Inc.
                157,938
             10,500
Essent Group Ltd.
                498,645
                  450
Humana Inc.
                188,663
               1,625
UnitedHealth Group Incorporated
                604,613
   
             1,449,859
     
 
Metal Mining (2.46%)
 
               3,500
Rio Tinto plc
                271,775
     
 
Non-Depository Credit Institutions (8.45%)
 
               1,000
Credit Acceptance Corporation (a)
360,230
               2,300
Discover Financial Services
                218,477
               4,600
Enova International, Inc. (a)
                163,208
               3,600
OneMain Holdings, Inc.
                193,392
   
                935,307
     
 
Petroleum Refining and Related Industries (1.88%)
 
8,000
Valvoline Inc.
208,560
     
 
Retail Consulting and Investment (0.00%)
 
             72,728
Amerivon Holdings LLC (a) (b)
0
     
 
Security and Commodity Brokers, Dealers, Exchanges, and Services (8.50%)
 
               1,200
Ameriprise Financial, Inc.
                278,940
                  400
BlackRock, Inc.
                301,584
               2,101
T. Rowe Price Group, Inc.
                360,531
   
                941,055
     
 
Transportation by Air (1.65%)
 
               3,000
Southwest Airlines Co. (a)
                183,180
     
 
Wholesale Trade - Nondurable Goods (1.93%)
 
               4,050
Nu Skin Enterprises, Inc.
                214,205
     
 
Total common stocks (Cost $7,406,476)
           11,418,305
     
 
Preferred Stocks (0.80%)
 
 
Retail Consulting and Investment (0.80%)
 
           245,268
Amerivon Holdings LLC (Cost $497,531) (b)
                  88,296
     
 
Total investments  (Cost $7,904,007) (103.94%) (c)
           11,506,601
 
Liabilities in excess of cash and other assets (-3.94%)
               (436,117)
     
 
Net assets (100.00%)
 $        11,070,484
     
     
(a) Non-income producing.
 
(b) Illiquid and/or restricted security that has been fair valued.
 
(c) The Fund's total investment portfolio value of $11506,601 has been pledged as collateral for borrowings under the Fund's credit facility.  As of March 31, 2021, there was $471,200 in outstanding borrowing.


Notes to Schedule of Portfolio Investments (Unaudited)

Valuation of Investments
Portfolio securities are valued by various methods depending on the primary market or exchange on which they trade. Most equity securities for which the primary market is in the United States are usually valued at the official closing price, last sale price or, if no sale has occurred, at the closing bid price. Most equity securities for which the primary market is outside the United States are usually valued using the official closing price or the last sale price in the principal market in which they are traded. If the last sale price on the local exchange is unavailable, the last evaluated quote or closing bid price normally is used. In the event of an unexpected closing of the primary market or exchange, a security may continue to trade on one or more other markets, and the price as reflected on those other trading venues may be more reflective of the security’s value than an earlier price from the primary market or exchange. Accordingly, Foxby Corp. (the “Fund”) may seek to use these additional sources of pricing data or information when prices from the primary market or exchange are unavailable or are earlier and less representative of current market value. Certain debt securities may be priced through pricing services that may utilize a matrix pricing system which takes into consideration factors such as yields, prices, maturities, call features, and ratings on comparable securities or according to prices quoted by a securities dealer that offers pricing services. Open end investment companies are valued at their net asset value. Foreign securities markets may be open on days when the U.S. markets are closed. For this reason, the value of any foreign securities owned by the Fund could change on a day when shareholders cannot buy or sell shares of the Fund. Securities for which market quotations are not readily available or reliable and other assets may be valued as determined in good faith by the Investment Manager under the direction of or pursuant to procedures approved by the Fund’s Board of Directors, called “fair value pricing.” Due to the inherent uncertainty of valuation, fair value pricing values may differ from the values that would have been used had a readily available and reliable market quotation for the securities existed. These differences in valuation could be material. A security’s valuation may differ depending on the method used for determining value. The use of fair value pricing by the Fund may cause the net asset value of its shares to differ from the net asset value that would be calculated using market prices. A fair value price is an estimate and there is no assurance that such price will be at or close to the price at which a security is next quoted or traded.

Value Measurements
Inputs to valuation methods are prioritized by a three level hierarchy as follows:

• Level 1 – unadjusted quoted prices in active markets for identical assets or liabilities including securities actively traded on a securities exchange.
 
• Level 2 – observable inputs other than quoted prices included in level 1 that are observable for the asset or liability which may include quoted prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates, and similar data.

• Level 3 – unobservable inputs for the asset or liability including the Fund’s own assumptions about the assumptions a market participant would use in valuing the asset or liability.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets for the security, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for investments categorized in level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs and methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

The following is a description of the valuation techniques applied to the Fund’s major categories of assets and liabilities measured at fair value on a recurring basis:

Equity securities (common and preferred stock) – Most publicly traded equity securities are valued normally at the most recent official closing price, last sale price, evaluated quote, or closing bid price. To the extent these securities are actively traded and valuation adjustments are not applied, they may be categorized in level 1 of the fair value hierarchy. Equities on inactive markets or valued by reference to similar instruments may be categorized in level 2.

Restricted and/or illiquid securities – Restricted and/or illiquid securities for which quotations are not readily available or reliable may be valued with fair value pricing as determined in good faith by the Investment Manager under the direction of or pursuant to procedures approved by the Fund’s Board of Directors. Restricted securities issued by publicly traded companies are generally valued at a discount to similar publicly traded securities. Restricted or illiquid securities issued by nonpublic entities may be valued by reference to comparable public entities or fundamental data relating to the issuer or both or similar inputs. Depending on the relative significance of valuation inputs, these instruments may be categorized in either level 2 or level 3 of the fair value hierarchy.

The following is a summary of the inputs used as of March 31, 2021 in valuing the Fund’s assets. Refer to the Schedule of Portfolio Investments for detailed information on specific investments.


Assets
Level 1
Level 2
Level 3
Total
 
Investments, at value
       
   
Common stocks
$    11,418,305
$              -
$            0
$  11,418,305
   
Preferred stocks
- 
                - 
       88,296
          88,296
 
Total investments, at value
$    11,418,305
$              -
$      88,296
$  11,506,601


The following is a reconciliation of level 3 assets:


   
Common
Stocks
Preferred
Stocks
Total
Balance of level 3 assets at December 31, 2020
$          0
$           85,844
$      85,844
Change in unrealized depreciation
            -
               3,077
          3,077
Balance at March 31, 2021
$          0
$           88,296
$      88,296
Net change in unrealized depreciation attributable to assets still held as level 3 at March 31, 2021
$          -
$             3,077
$       3,077


There were no transfers into or out of level 3 assets during the period.
 
The Investment Manager, under the direction of the Fund’s Board of Directors, considers various valuation approaches for valuing assets categorized within level 3 of the fair value hierarchy. The factors used in determining the value of such assets may include, but are not limited to: the discount applied due to the private nature of the asset; the type of the security; the size of the asset; the initial cost of the security; the existence of any contractual restrictions on the security’s disposition; the price and extent of public trading in similar securities of the issuer or of comparable companies; quotations or evaluated prices from broker-dealers and/or pricing services; information obtained from the issuer or analysts; an analysis of the company’s or issuer’s financial statements; or an evaluation of the forces that influence the issuer and the market in which the asset is purchased and sold. Significant changes in any of those inputs in isolation may result in a significantly lower or higher fair value measurement. The pricing of all fair value assets is normally reported to the Fund’s Board of Directors.
 
The following table presents additional information about valuation methodologies and inputs used for assets that are measured at fair value and categorized as level 3 as of March 31, 2021:

 
Fair Value
 Valuation Technique
   Unobservable Input
Range
Common stocks
       
 
Retail Consulting and Investment
$       0
Value of liquidation preference per share
Discount rate due to lack of marketability
80%
Preferred stocks
       
 
Retail Consulting and Investment
$  88,296
Value of liquidation preference per share
Discount rate due to lack of marketability
80%

Cost for Federal Income Tax Purposes
As of March 31, 2021, for federal income tax purposes, subject to change, the aggregate cost of securities was $7,904,007 and net unrealized appreciation was $3,604,594, comprised of gross unrealized appreciation of $4,034,654 and gross unrealized depreciation of $432,060. The aggregate cost of investments for tax purposes will depend upon the Fund’s investment experience during the entirety of its fiscal year and may be subject to changes based on tax regulations.



Illiquid and Restricted Securities
The Fund owns securities which have a limited trading market and/or certain restrictions on trading and, therefore, may be considered illiquid and/or restricted. Such securities have been valued using fair value pricing. Due to the inherent uncertainty of valuation, fair value pricing values may differ from the values that would have been used had a readily available market for the securities existed. These differences in valuation could be material. Illiquid and/or restricted securities owned as of March 31, 2021 were as follows:

 
Acquisition Date
Cost
Value
Amerivon Holdings LLC preferred shares
9/20/07
$      497,531
$   88,296
Amerivon Holdings LLC common equity units
9/20/07
                  0
              0
Total
 
$     497,531
$   88,296
Percent of net assets
 
              4%
         1%


Foreign Securities Risk
Investments in the securities of foreign issuers involve special risks which include changes in foreign exchange rates and the possibility of future adverse political, tax, and economic developments which could adversely affect the value of such securities. Moreover, securities of foreign issuers and securities traded in foreign markets may be less liquid and their prices more volatile than those of U.S. issuers and markets. In addition, in certain foreign countries, there is the possibility of expropriation or confiscatory taxation, political, or social instability, or diplomatic developments that could affect U.S. investments in the securities of issuers domiciled in those countries.

Coronavirus (COVID-19) Pandemic
During 2020, the World Health Organization declared COVID-19 to be a public health emergency. COVID-19 has led to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets in general. COVID-19 may adversely impact the Funds ability to achieve their investment objectives. Because of the uncertainties on valuation, the global economy and business operations, values reflected in these financial statements may materially differ from the value received upon actual sales of those investments. The extent of the impact on the performance of the Funds and their investments will depend on future developments, including, but not limited to, the duration and spread of the COVID19 outbreak, related restrictions and advisories, and the effects on the financial markets and economy overall, all of which are highly uncertain and cannot be predicted.